These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 28408103)

  • 1. Effect of CPAP on diastolic function in coronary artery disease patients with nonsleepy obstructive sleep apnea: A randomized controlled trial.
    Glantz H; Johansson MC; Thunström E; Guron CW; Uzel H; Saygin M; Herlitz J; Peker Y
    Int J Cardiol; 2017 Aug; 241():12-18. PubMed ID: 28408103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstructive sleep apnea is independently associated with worse diastolic function in coronary artery disease.
    Glantz H; Thunström E; Johansson MC; Wallentin Guron C; Uzel H; Ejdebäck J; Nasic S; Peker Y
    Sleep Med; 2015 Jan; 16(1):160-7. PubMed ID: 25547036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term use of continuous positive airway pressure therapy in coronary artery disease patients with nonsleepy obstructive sleep apnea.
    Luyster FS; Strollo PJ; Thunström E; Peker Y
    Clin Cardiol; 2017 Dec; 40(12):1297-1302. PubMed ID: 29243273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial.
    Peker Y; Glantz H; Eulenburg C; Wegscheider K; Herlitz J; Thunström E
    Am J Respir Crit Care Med; 2016 Sep; 194(5):613-20. PubMed ID: 26914592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Positive Airway Pressure Treatment and Depression in Adults with Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea. A Secondary Analysis of the RICCADSA Trial.
    Balcan B; Thunström E; Strollo PJ; Peker Y
    Ann Am Thorac Soc; 2019 Jan; 16(1):62-70. PubMed ID: 30130421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and predictors of obstructive sleep apnea in a revascularized coronary artery disease cohort.
    Glantz H; Thunström E; Herlitz J; Cederin B; Nasic S; Ejdebäck J; Peker Y
    Ann Am Thorac Soc; 2013 Aug; 10(4):350-6. PubMed ID: 23952854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPAP and Health-Related Quality of Life in Adults With Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea in the RICCADSA Trial.
    Wallström S; Balcan B; Thunström E; Wolf A; Peker Y
    J Clin Sleep Med; 2019 Sep; 15(9):1311-1320. PubMed ID: 31538602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPAP Does Not Reduce Inflammatory Biomarkers in Patients With Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea: A Randomized Controlled Trial.
    Thunström E; Glantz H; Yucel-Lindberg T; Lindberg K; Saygin M; Peker Y
    Sleep; 2017 Nov; 40(11):. PubMed ID: 29029237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure.
    Johnson CB; Beanlands RS; Yoshinaga K; Haddad H; Leech J; de Kemp R; Burwash IG
    Can J Cardiol; 2008 Sep; 24(9):697-704. PubMed ID: 18787720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous positive airway pressure treatment and anxiety in adults with coronary artery disease and nonsleepy obstructive sleep apnea in the RICCADSA trial.
    Celik Y; Thunström E; Strollo PJ; Peker Y
    Sleep Med; 2021 Jan; 77():96-103. PubMed ID: 33341644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular systolic and diastolic function in obstructive sleep apnea: impact of continuous positive airway pressure therapy.
    Butt M; Dwivedi G; Shantsila A; Khair OA; Lip GY
    Circ Heart Fail; 2012 Mar; 5(2):226-33. PubMed ID: 22414938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea.
    Barbé F; Durán-Cantolla J; Capote F; de la Peña M; Chiner E; Masa JF; Gonzalez M; Marín JM; Garcia-Rio F; de Atauri JD; Terán J; Mayos M; Monasterio C; del Campo F; Gomez S; de la Torre MS; Martinez M; Montserrat JM;
    Am J Respir Crit Care Med; 2010 Apr; 181(7):718-26. PubMed ID: 20007932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Outcomes in Adults with Coronary Artery Disease and Obstructive Sleep Apnea with versus without Excessive Daytime Sleepiness in the RICCADSA Cinical Trial.
    Eulenburg C; Celik Y; Redline S; Thunström E; Glantz H; Strollo PJ; Peker Y
    Ann Am Thorac Soc; 2023 Jul; 20(7):1048-1056. PubMed ID: 36800433
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of CPAP treatment on leptin and adiponectin in adults with coronary artery disease and nonsleepy obstructive sleep apnoea in the RICCADSA trial.
    Balcan B; Thunström E; Yucel-Lindberg T; Lindberg K; Ay P; Peker Y
    Sleep Med; 2020 Mar; 67():7-14. PubMed ID: 31884309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular torsion in patients with obstructive sleep apnoea before and after continuous positive airway pressure therapy: assessment by two-dimensional speckle tracking echocardiography.
    Vural MG; Çetin S; Keser N; Firat H; Akdemir R; Gunduz H
    Acta Cardiol; 2017 Dec; 72(6):638-647. PubMed ID: 28660792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Benefit of Continuous Positive Airway Pressure in Adults with Coronary Artery Disease and Obstructive Sleep Apnea without Excessive Sleepiness.
    Azarbarzin A; Zinchuk A; Wellman A; Labarca G; Vena D; Gell L; Messineo L; White DP; Gottlieb DJ; Redline S; Peker Y; Sands SA
    Am J Respir Crit Care Med; 2022 Sep; 206(6):767-774. PubMed ID: 35579605
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: a randomized study.
    Hall AB; Ziadi MC; Leech JA; Chen SY; Burwash IG; Renaud J; deKemp RA; Haddad H; Mielniczuk LM; Yoshinaga K; Guo A; Chen L; Walter O; Garrard L; DaSilva JN; Floras JS; Beanlands RS
    Circulation; 2014 Sep; 130(11):892-901. PubMed ID: 24993098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure.
    Shivalkar B; Van de Heyning C; Kerremans M; Rinkevich D; Verbraecken J; De Backer W; Vrints C
    J Am Coll Cardiol; 2006 Apr; 47(7):1433-9. PubMed ID: 16580533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive sleep apnea and self-reported functional impairment in revascularized patients with coronary artery disease in the RICCADSA trial.
    Baniak LM; Chasens ER; Luyster FS; Strollo PJ; Thunström E; Peker Y
    Sleep Breath; 2018 Dec; 22(4):1169-1177. PubMed ID: 30324547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticyclic modulated ventilation versus continuous positive airway pressure in patients with coexisting obstructive sleep apnea and Cheyne-Stokes respiration: a randomized crossover trial.
    Galetke W; Ghassemi BM; Priegnitz C; Stieglitz S; Anduleit N; Richter K; Randerath WJ
    Sleep Med; 2014 Aug; 15(8):874-9. PubMed ID: 24841107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.